[libribook.com] Traumatic Scar Tissue Management 1st Edition
TechniquesTechniques commonly employed are superficial fluid techniques and neuralsedation. Judicious use of gentle CT and fascial techniques, in the form of brief,light-cyclical stretch/loading, are also indicated. Barrier should not be engagednear or around the injury site.
Dosage considerationsThe presence of pain and inflammation are the primary indicators for treatment.The client’s tolerance level may indicate a shorter duration treatment of 30minutes, otherwise the typical duration of 60 minutes is indicated. Frequency of1–3 treatments per week is a general guideline. Early stage care will typically beimplemented for 6–12 weeks, followed by the transition to later stage care.
- Page 681 and 682: Clinical ConsiderationMT has been f
- Page 683 and 684: Clinical ConsiderationMassage can h
- Page 685 and 686: Health History and InterviewA stand
- Page 687 and 688: surrounding muscle structures that
- Page 689 and 690: we are gathering information about
- Page 691 and 692: Keep in mind that the therapist’s
- Page 693 and 694: Continuous evaluation during the se
- Page 695 and 696: Pre-treatment assessment/evaluation
- Page 697 and 698: Scar scalesScar scales can be used
- Page 699 and 700: response to negative pressure. It h
- Page 701 and 702: • Client self-management strategi
- Page 703 and 704: BindOnce barrier is reached or surp
- Page 705 and 706: Table 9.1Comparative of normal and
- Page 707 and 708: 2-3 times a year effectively addres
- Page 709 and 710: Myofascial meridian exampleSuperfic
- Page 711: Clinical ConsiderationKnee and back
- Page 715 and 716: Clinical ConsiderationApplication t
- Page 717 and 718: Pathophysiological ConsiderationMec
- Page 719 and 720: Clinical ConsiderationStecco and co
- Page 721 and 722: Safety FirstMT appears to have few
- Page 723 and 724: Deep workThe deep techniques noted
- Page 725 and 726: Psychological considerationsIt is w
- Page 727 and 728: Clinical ConsiderationMT dosage and
- Page 729 and 730: Developing a sound treatment strate
- Page 731: Treatment outcomesEssentially, earl
- Page 735 and 736: Clinical ConsiderationNumerous syst
- Page 737 and 738: Clinical ConsiderationHeat in the t
- Page 739 and 740: Clinical ConsiderationBest and co-w
- Page 741 and 742: Pathophysiological considerationCom
- Page 743 and 744: Clinical ConsiderationTiming is eve
- Page 745 and 746: Clinical ConsiderationEvidence sugg
- Page 747 and 748: Clinical ConsiderationSeveral studi
- Page 749 and 750: Clinical ConsiderationPreventive me
- Page 751 and 752: Pathophysiological ConsiderationWit
- Page 753 and 754: TechniquesCommonly employed techniq
- Page 755 and 756: Treatment outcomesThe later stages
- Page 757 and 758: Clinical ConsiderationsNon-threaten
- Page 759 and 760: Clinical ConsiderationsIt has been
- Page 761 and 762: Clinical ConsiderationsMT may be a
- Page 763 and 764: Pathophysiological ConsiderationUnd
- Page 765 and 766: Clinical ConsiderationsIn the early
- Page 767 and 768: Clinical ConsiderationsAs the remod
- Page 769 and 770: Treatment outcomesEssentially, the
- Page 771 and 772: Dosage considerationsThe presence o
- Page 773 and 774: TechniquesAny carpenter will tell y
- Page 775 and 776: Pressure Level 4 - Strong pressure/
- Page 777 and 778: Grade 7 and 8• Firm, deep• Trig
- Page 779 and 780: Neutralize pHFacilitate healing pro
- Page 781 and 782: Manual Lymphatic TechniquesEarly ma
Dosage considerations
The presence of pain and inflammation are the primary indicators for treatment.
The client’s tolerance level may indicate a shorter duration treatment of 30
minutes, otherwise the typical duration of 60 minutes is indicated. Frequency of
1–3 treatments per week is a general guideline. Early stage care will typically be
implemented for 6–12 weeks, followed by the transition to later stage care.